0001209191-23-001757.txt : 20230105 0001209191-23-001757.hdr.sgml : 20230105 20230105160036 ACCESSION NUMBER: 0001209191-23-001757 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230104 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oestreich Stephanie CENTRAL INDEX KEY: 0001901450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39655 FILM NUMBER: 23511189 MAIL ADDRESS: STREET 1: 75 STATE STREET, SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galecto, Inc. CENTRAL INDEX KEY: 0001800315 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371957007 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 45-70-70-52-10 MAIL ADDRESS: STREET 1: 75 STATE STREET STREET 2: SUITE 100 CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Galecto Inc. DATE OF NAME CHANGE: 20200116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-04 0 0001800315 Galecto, Inc. GLTO 0001901450 Oestreich Stephanie C/O GALECTO, INC. OLE MAALOES VEJ 3 OLE MAALOES VEJ 3 G7 DK-2200 DENMARK 0 1 0 0 Chief Business Officer Stock Option (right to buy) 1.21 2023-01-04 4 A 0 80000 0.00 A 2033-01-03 Common Stock 80000 80000 D 25% of the shares subject to such option vested and became exercisable on January 4, 2024 and the remainder of the shares vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. /s/ Garrett Winslow, Attorney-in-fact 2023-01-05